Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Seeking the world’s best science images
Seeking the world’s best science images
RPS calls for entries to the International Images for Science exhibition
Dover realigns pump businesses into three focused companies
Dover realigns pump businesses into three focused companies
Names new leaders of each company
Catalent makes another promotion
Catalent makes another promotion
Mark Bisset moves up to President, Catalent Asia Pacific
Allied-Bristol Life Sciences appoints Satish Jindal
Allied-Bristol Life Sciences appoints Satish Jindal
Former Bristol-Meyers Squibb President to lead discovery of drug candidates from leading academic institutions
New Chief Medical Officer for Cardio3 Biosciences
New Chief Medical Officer for Cardio3 Biosciences
Warren Sherman has more than three decades of experience in the cardiovascular and cell therapy fields
Rapid Micro Biosystems announces new Chief Executive
Rapid Micro Biosystems announces new Chief Executive
Life sciences veteran joins the US company
Novartis to make changes to Executive Committee after conclusion of deals with GSK and Eli Lilly
Novartis to make changes to Executive Committee after conclusion of deals with GSK and Eli Lilly
Three heads of Novartis divisions to leave Executive Committee
Aesica appoints VP, Business Development and Business Development Director for Finished Dose
Aesica appoints VP, Business Development and Business Development Director for Finished Dose
To drive service in Europe and achieve further growth
Steven Fasman joins Catalent as SVP and General Counsel
Steven Fasman joins Catalent as SVP and General Counsel
With extensive legal experience across a broad range of industries
Mark Griffiths joins board of Dishman Pharmaceuticals and Chemicals
Mark Griffiths joins board of Dishman Pharmaceuticals and Chemicals
He has been Chief Executive of Dishman and Carbogen Amcis for three years
Aptuit appoints Operations and General Manager in Verona, Italy
Aptuit appoints Operations and General Manager in Verona, Italy
Manuela Leone will oversee Aptuit’s drug discovery and development operations
West promotes Karen Flynn to President of Pharmaceutical Packaging Systems
West promotes Karen Flynn to President of Pharmaceutical Packaging Systems
She brings more than 28 years of experience to the role
Kathleen Glaub joins Codexis board
Kathleen Glaub joins Codexis board
Brings 30 years of drug development experience to the position
New Chair and Deputy Chair elected to ECHA Management Board
New Chair and Deputy Chair elected to ECHA Management Board
Nina Cromnier has been re-elected as Chair while Karel Blaha becomes the new Deputy Chair
ADC Therapeutics adds eight new members of staff
ADC Therapeutics adds eight new members of staff
As the company continues to expand its pipeline of antibody drug conjugates
Nanobiotix expands operations into the US
Nanobiotix expands operations into the US
Senior pharmaceutical executive appointed as Vice President of Corporate Development
Previous
1
…
123
124
125
126
(current)
127
128
129
…
216
Next
Trending Articles
New Managing Director for Shimadzu Europa
Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European organisation and more than 39 years in the company in total
BioDuro appoints Greg Makara to lead discovery chemistry
BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks to strengthen its early-stage drug discovery capabilities.
EyeC expands OEM growth with new business development manager
Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
Three new commercial appointments for Symbiosis
Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across Asia-Pacific, the Middle East and Southern Europe
Lonza nominates Pearl Huang to board
Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug discovery and innovation